Tag: antidepressants

The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.

Peter Simons covers a paper arguing that “psychology is fundamentally incompatible with hypothesis-driven theoretical science,” another paper finding that evidence-based medicine is more corporate gimmick than reliable science, a study that found psychiatrists deliver the worst-quality healthcare of any medical specialty, and more!

Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.

A new study found that taking antidepressants did not improve quality of life.

According to patient reports, SSRI antidepressants most frequently lead to the subjective experience of emotional blunting.

A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.

Health and wellbeing in young people are trending down in New Zealand. Are antidepressants to blame?

Drug regulators frequently approve drugs despite contradictory clinical trial results and without evidence of clinical benefits.

Researchers argue that we need a paradigm shift away from the biomedical model of mental illness to one informed by political action and common sense.

A review of research on antidepressant efficacy finds that an unfavorable risk-to-benefit ratio.

A meta-analysis published last month showed that psychotherapy has an enduring effect on depression—in contrast to depression pills.

Meta-analysis finds that the placebo run-in methodology reduces the placebo effect and finds antidepressants to be less useful.

Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.

Jim van Os and Peter Groot discuss their paper: “Successful Use of Tapering Strips for Hyperbolic Reduction of Antidepressant Dose: A Cohort Study” published in the journal Therapeutic Advances in Psychopharmacology.

In May 2021, Cochrane published a network meta-analysis of depression pills for children. The abstract is misleading and reads like drug company marketing.

A researcher and service user Stevie Lewis recounts her own experience with antidepressant withdrawal and what she wishes her doctors knew.

Researchers again debunk the claim that the FDA black box warnings on antidepressants led to more suicides.

“Short and simple psychological programs can prevent people from relapsing when they stop their antidepressants.”

The prominent psychiatrist explores why antidepressants remain highly overprescribed and offers solutions to the problem.

On Denmark's declining use of depression pills for children, and why one should never stop fighting to change psychiatry and society's reliance on it.

Researchers find a lack of current literature on safe, effective ways to manage antidepressant withdrawal and make suggestions for future research.

The psychiatrists have fought really hard to hide the terrible truth that depression pills double the risk of suicide, not only in children but also in adults.

After 15 years, the founder of SurvivingAntidepressants.org, Adele Framer, shares what she has learned about the science of withdrawing from psychiatric drugs.

Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.

Bias and financial conflicts in antidepressant trials “contribute to systematic underestimation of risk in the published literature.”